Tian Zhang, MD Duke University Medical Center, discusses Early Phase VEGF Trials Enhance Responses in the 1st Line Could lead to improved outcomes of progression-free & overall survival at Kidney Cancer Association 2017 in Miami.
Early Phase VEGF Trials Enhance Responses in the 1st Line Could lead to improved outcomes of progression-free & overall survival
